Evidence map›Paper›PMID 35257332›Full record

ReviewEnvironmental science and pollution research international2022

Graphene-based photocatalytic nanocomposites used to treat pharmaceutical and personal care product wastewater: A review.

Caifang Li, Xianliang Wu, Jiwei Hu, Junyue Shan, Zhenming Zhang, Xianfei Huang, Huijuan Liu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 13 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Caifang Li *Guizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, Guiyang, 550001, China.
Xianliang Wu *Guizhou Institute of Biology, Guiyang, Guizhou, 550009, China.
Jiwei HuGuizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, Guiyang, 550001, China.
Junyue ShanGuizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, Guiyang, 550001, China.
Zhenming ZhangGuizhou Institute of Biology, Guiyang, Guizhou, 550009, China.
Xianfei HuangGuizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, Guiyang, 550001, China. hxfswjs@gznu.edu.cn.ORCID http://orcid.org/0000-0003-4474-459X
Huijuan LiuThe Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, 550025, China.
Guizhou Normal University · CNGuizhou Institute of Biology · CNGuiyang Medical University · CN

Funding

of Cu(II) from aqueous solution on fl No. [2017] 5726-42Startup Project for High-level Talents of Guizhou Institute of Technology No. School Bo He J Zi [2021] 007
6 · The paper itself

Abstract

Photocatalytic technology has been widely studied by researchers in the field of environmental purification. This technology can not only completely convert organic pollutants into small molecules of CO

Indexed as

CosmeticsEnvironmental PollutantsGraphiteNanocompositesPharmaceutical PreparationsWastewaterCosmeticsEnvironmental PollutantsGraphitePharmaceutical PreparationsWastewaterGraphene-based nanocompositesMagnetic separationPharmaceuticals and personal care productsPhotocatalystsSemiconductor

Identifiers

PMID35257332
OpenAlexW4221065611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.